Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids

Diseases and Conditions Researched


What is the purpose of this trial?

The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.

Participation Guidelines

Age: 6 Years - 16 Years
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Purdue Pharma LP
Dates: August 30, 2010
Last Updated: March 20, 2013
Study HIC#: 1107008863 ID: NCT01192295